Results 231 to 240 of about 58,972 (283)

Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis. [PDF]

open access: yesUnited European Gastroenterol J
Hart A   +15 more
europepmc   +1 more source

Dosing Biologic Drugs for Patients With Obesity: One Size Does Not Fit All

open access: yes
Arthritis &Rheumatology, Volume 78, Issue 6, Page 1206-1209, June 2026.
Stephen J. Balevic   +2 more
wiley   +1 more source

Dercum Disease: Exploratory Therapeutic Approaches in the Absence of Standardized Medical Treatment-A Single Center Case Series. [PDF]

open access: yesLife (Basel)
Magnatta A   +16 more
europepmc   +1 more source

Esperienze su Infliximab

open access: yes, 2009
G. Altomare
core  

Infliximab

Dermatologic Therapy, 2004
Infliximab is a chimeric monoclonal antibody that interferes with the actions of the pro-inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha). Clinical trials of infliximab have demonstrated a rapid and substantial response in patents with psoriasis and psoriatic arthritis, substantiating the role of TNF-alpha in the immunopathogenesis of ...
Laura S, Winterfield, Alan, Menter
openaire   +3 more sources

Home - About - Disclaimer - Privacy